Insud Pharma
Emmanuel Morlet has a strong background in finance and auditing. Emmanuel has worked for various companies in positions such as Internal Audit & Risk Management Director, Administration & Accounting Director, and Group Business Controller Manager. In these roles, they have been responsible for implementing internal audit functions, conducting audits of subsidiaries worldwide, analyzing risk maps, and managing financial operations. Emmanuel has also overseen the commercial and industrial activities of global groups, including reporting, forecasting, budgeting, and business planning. With a team of 15 people, they have demonstrated leadership skills and the ability to present results and budgets to senior management. Overall, Emmanuel Morlet's experience reflects their expertise in financial management, controlling, and project management.
Emmanuel Morlet attended the Université Paris 13 from 1991 to 1994, where they earned a Magistère degree in Industrial Economics. In 1994, they also completed a DEA degree in Industrial Organization, Innovation, and International Strategy at the same university. Prior to that, they obtained a DEUG in Economics from the Université d'Auvergne in 1990-1991. More recently, in 2014-2015, they participated in the Corporate Management Program at the IESE Business School.
Insud Pharma
5 followers
INSUD PHARMA operates across the entire pharmaceutical value chain, delivering specialized expertise and experience in scientific research, development, manufacturing, sales and marketing of a wide range of value-adding active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals, for human and animal health. While the main offices are located in Madrid, Lugano, Buenos Aires, INSUD PHARMA is acting worldwide, creating a broad and balanced manufacturing and commercial network across Europe, America, Asia and Africa, to address global opportunities and customers` needs in all major pharmaceutical markets. INSUD PHARMA's activity is organized in three synergistic business areas: Industrial (Chemo), Branded (Exeltis) and Biotech (mAbxience), with over 7,300 professionals in more than 50 countries, 18 state-of-the-art facilities, 15 specialized R&D centers, 12 commercial offices and more than 35 pharmaceutical affiliates, serving 1,150 customers in 96 countries around the world. INSUD PHARMA believes in innovation and sustainable development. Our commitment is to improve people`s health and quality of life, providing access to quality medicines at affordable prices, and to continuously expand our efforts and R&D investment to develop new and better therapies.